US stock · Healthcare sector · Medical Distribution
A
AmerisourceBergen Corporation
ABC
NYSE168.41
USD
-1.76
(-1.03%)
Market Closed
21.07P/E
13Forward P/E
0.87P/E to S&P500
34.048BMarket CAP
1.11%Div Yield
Upcoming Earnings
1 Aug-7 Aug
Shares Short
5/15/23
5.18M
Short % of Float
3.20%
Short % of Shares Outs.
2.56%
% Held by Insiders
16.96%
% Held by Institutions
77.94%
Beta
0.52
PEG Ratio
1.78
52w. high/low
176.62/135.14
Avg. Daily Volume
1.17M
Return %
Stock
S&P 500
1 year
8.09
2.12
3 years
82.86
40.04
5 years
97.99
54.55
Scale: |
High
Low
24.30
13.33
26.58
13.75
34.72
25.66
43.47
33.91
44.02
35.48
71.38
43.01
92.84
62.55
120.68
89.52
103.40
68.38
97.85
71.90
106.27
69.36
94.75
70.55
111.25
72.06
135.26
94.89
174.63
127.94
176.62
147.48
Currency: USD
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
Revenue per share
178.40
218.47
238.74
276.18
294.41
314.30
380.67
525.89
624.29
692.01
701.29
770.82
854.51
927.29
1,039.19
1,144.46
1,203.92
Earnings per share
1.27
0.78
1.67
2.26
2.59
2.84
1.88
1.22
(0.62)
6.73
1.67
7.61
4.07
(16.65)
7.48
8.15
7.87
FCF per share
2.94
1.87
2.12
3.27
3.67
4.51
2.53
5.27
16.94
12.79
4.75
4.93
9.68
8.97
10.82
10.59
11.90
Dividends per share
0.10
0.15
0.21
0.32
0.43
0.52
0.85
0.94
1.17
1.36
1.47
1.53
1.61
1.68
1.78
1.88
1.92
CAPEX per share
0.32
0.43
0.49
0.65
0.62
0.65
0.88
1.16
1.06
2.19
2.14
1.54
1.48
1.81
2.13
2.38
2.26
Book Value per sh.
8.37
8.44
9.04
10.47
10.52
9.71
10.04
8.61
2.91
10.03
9.45
13.46
13.70
(4.98)
1.08
(1.01)
0.99
Comm.Shares outs.
370
321
301
282
272
253
231
227
218
212
218
218
210
205
206
208
206
Avg. annual P/E ratio
19.3
25.1
11.8
13.3
14.9
13.7
30.2
61.5
(168.2)
12.3
51.7
11.6
20.4
(5.7)
15.7
18.3
21.1
P/E to S&P500
1.1
1.2
0.2
0.6
0.9
0.9
1.8
3.4
(8.4)
0.6
2.2
0.5
0.8
(0.1)
0.5
0.9
0.9
Avg. annual div. yield
0.4%
0.8%
1.1%
1.1%
1.1%
1.4%
1.5%
1.3%
1.1%
1.6%
1.7%
1.7%
1.9%
1.8%
1.5%
1.3%
1.2%
Revenue (m)
66,074
70,190
71,760
77,954
80,218
79,490
87,959
119,569
135,962
146,850
153,144
167,940
179,589
189,894
213,989
238,587
247,543
Operating margin
1.2%
1.2%
1.2%
1.4%
1.5%
1.6%
1.0%
0.7%
0.3%
1.0%
0.7%
0.9%
0.6%
(2.7)%
1.1%
1.0%
1.0%
Depreciation (m)
104
96
94
104
126
147
171
193
250
392
432
510
498
408
515
710
889
Net profit (m)
469
251
503
637
707
719
434
276
(135)
1,428
364
1,658
855
(3,409)
1,540
1,699
1,617
Income tax rate
37.1%
38.4%
37.9%
38.0%
37.5%
39.1%
40.2%
57.8%
149.2%
(2.7)%
60.3%
(37.2)%
11.7%
35.8%
30.5%
23.7%
20.4%
Net profit margin
0.7%
0.4%
0.7%
0.8%
0.9%
0.9%
0.5%
0.2%
(0.1)%
1.0%
0.2%
1.0%
0.5%
(1.8)%
0.7%
0.7%
0.7%
Working capital (m)
857
502
474
842
363
(227)
(477)
(450)
(2,366)
(2,429)
(2,515)
(1,975)
(1,449)
(797)
(2,556)
(3,888)
(5,081)
Long-term debt (m)
1,227
1,187
1,177
1,343
973
1,447
1,397
1,996
3,493
3,594
3,430
4,159
4,034
3,618
6,384
4,632
4,667
Equity (m)
3,100
2,710
2,716
2,954
2,867
2,457
2,320
1,957
634
2,129
2,064
2,933
2,879
(1,019)
223
(212)
511
ROIC
10.7%
8.3%
13.3%
15.1%
18.3%
18.3%
12.4%
7.3%
(3.7)%
18.8%
5.0%
20.0%
10.8%
(32.3)%
10.7%
14.6%
14.6%
Return on capital
6.2%
4.4%
6.4%
7.6%
8.1%
8.2%
4.4%
3.5%
1.4%
4.6%
3.0%
3.8%
3.0%
(11.7)%
4.2%
4.3%
4.3%
Return on equity
15.1%
9.2%
18.5%
21.6%
24.6%
29.3%
18.7%
14.1%
(21.3)%
67.1%
17.7%
56.5%
29.7%
334.5%
689.5%
(803.0)%
316.3%
Plowback ratio
92.1%
80.6%
87.5%
85.8%
83.4%
81.5%
54.9%
22.4%
288.2%
79.8%
12.1%
79.9%
60.4%
110.1%
76.2%
76.5%
74.8%
Div.&Repurch./FCF
126.5%
107.5%
80.4%
60.7%
95.8%
113.5%
116.1%
80.8%
- -
94.1%
62.7%
90.4%
49.8%
- -
20.1%
39.7%
68.4%
Capital Structure
2 May · 2023 | Q2
All numbers in millions
Total liabilities
$ 58,255
Total assets
$ 58,766
Long-term debt
$ 4,667
Cash and equiv.
$ 1,539
Goodwill
$ 9,634
Retained earnings
$ 3,691
Common stock
202
Enterprise Value
$ 37,175
Working Capital
Currency: USD, in millions
2020
2021
2022
Cash & Investments
4,598
2,547
3,388
Receivables
14,335
18,389
18,625
Inventory
12,589
15,368
15,556
Other
1,534
447
810
Current assets
33,056
38,803
39,590
Acc. Payable
31,705
38,010
40,193
Debt due
501
300
1,070
Other
1,647
3,048
2,215
Current liabilities
33,853
41,359
43,478
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
11.50%
9.21%
12.05%
Cash flow
(0.97)%
24.96%
36.41%
Earnings
10.32%
(170.45)%
(193.88)%
Dividends
6.83%
4.17%
8.14%
Book value
(194.72)%
(113.47)%
(29.11)%
Insider Trading
Type
Shares
Date
Cleary James F
Exempt
38,376
05/18/23
Cleary James F
Exempt
38,376
05/18/23
Cleary James F
InKind
25,831
05/18/23
Campbell Elizabeth S
Exempt
3,305
05/17/23
Campbell Elizabeth S
Sale
3,305
05/17/23
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2021
52,517
49,154
53,406
58,912
213,989
2022
59,629
57,719
60,065
61,174
238,587
2023
62,847
63,457
- -
- -
- -
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2021
1.82
2.11
1.42
2.13
7.48
2022
2.16
2.63
1.95
1.41
8.15
2023
2.35
2.15
- -
- -
- -
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2021
0.44
0.44
0.45
0.45
1.78
2022
0.48
0.47
0.47
0.46
1.88
2023
0.49
0.50
- -
- -
- -
Company Description
Sector:
Healthcare
Industry:
Medical Distribution
CEO:
Mr. Steven H. Collis
Full-time employees:
39,000
City:
Conshohocken
Address:
1 West First Avenue
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Recent News
· 24 Jan, 2023 · The Wall Street Journal
· 29 Dec, 2022 · The Wall Street Journal
· 28 Dec, 2022 · The Wall Street Journal
· 25 Feb, 2022 · The Wall Street Journal
· 2 Feb, 2022 · The Wall Street Journal
· 20 Jul, 2021 · The Wall Street Journal
· 26 Jun, 2021 · The Wall Street Journal